Health
Breast cancer patient given 24 months to live has ‘miraculous’ recovery, says God led her to cure
Less than three years ago, Tina Willits, now 53, thought she had just two years to live.
Today, she is cancer-free and wants the world to know about the treatment that saved her.
The Florida mother and grandmother first felt a lump in late 2021, just months after a normal mammogram.
BREAST CANCER VACCINE UPDATE FROM CLEVELAND CLINIC: ‘A NEW ERA’
In March 2022, she discovered that she had HER2 positive breast cancer, an aggressive form of the disease in which the cancer cells have an abnormally high level of a protein called human epidermal growth factor receptor 2 (HER2).
“I still remember the doctor coming in and telling us that it was in my lymph nodes, ribs, spine, sternum and bones,” Willits told Fox News Digital during an on-camera interview. (See the video at the top of this article.)
Florida mother and grandmother Tina Willits, now 53, thought she had just two years to live, but today she is cancer-free. (Tina Willits)
Willits was told that she had golf ball-sized tumors and that the disease was too advanced for a mastectomy. She was placed on end-of-care chemotherapy and told to “enjoy the time you have left.”
“The doctor told me, ‘We will try to stop the progression,’ but she said ‘the best we can probably offer you is about 24 months.’”
‘I wanted it gone’
Willits wasn’t satisfied with just stopping the progression of her cancer.
“I have five biological children and I was raising two of my bonus babies, and I had four grandkids at the time,” she said.
“And I was just determined that I wanted it gone. That was my goal. And I remember my oncologist telling me that was never going to happen.”
“The doctor told me, ‘The best we can offer you is about 24 months.’”
After doing some of her own research, Willits learned about an alternative treatment called immunotherapy, which uses the body’s immune system to identify and destroy cancer cells.
For decades, the go-to treatments for cancer have been chemotherapy, radiation and surgery — but some experts are calling immunotherapy the “fourth pillar” of cancer treatments.
“I have five biological children and I was raising two of my bonus babies, and I had four grandkids at the time,” said Willits about why she was so determined to beat cancer. (Tina Willits)
In her research, she came across Dr. Jason R. Williams of The Williams Cancer Institute in California, who offers a new cancer therapy that uses cold gases and the body’s own cells to freeze and fight tumors.
“Immunotherapy teaches the immune system to attack the cancer,” Williams told Fox News Digital. “So, like a vaccine, it can give you a long-term, durable response. This is what is needed to achieve cures.”
4 HIDDEN SIGNS OF BREAST CANCER TO WATCH FOR: ‘YOU KNOW YOUR BODY’
Willits and her husband reached out to the doctor, who immediately began looking into her case.
“She physically was in good condition, even though her cancer was advanced,” Williams said about Willits. “She was on chemo, but still remained in very good health, even though she was advanced and metastatic.”
He added, “I was confident, but cautious. Cancer is a very challenging foe.”
Willits is pictured at her wedding, before being diagnosed with aggressive breast cancer. “I’m a part of my family’s life every day,” she told Fox News Digital. (Tina Willits)
Williams offered Willits something she hadn’t had until then: hope.
“He was just unbelievable. After seeing all of my tests, he said, ‘I can cure you,’” she told Fox News Digital. “And you don’t get those words as a stage 4 patient.”
Six weeks after receiving a course of immunotherapy treatments — in conjunction with supplements to ramp up the immune system and cryoablation, a procedure that uses freezing temperatures to destroy cancer cells — a PET scan revealed that Willits’ cancer was gone.
ENDOMETRIAL CANCER PATIENTS SEE NEW HOPE AS FDA APPROVES ‘TRANSFORMING’ IMMUNOTHERAPY DRUG
Today, Willits said, she is stable and healthy.
“I exercise every day. I’m a part of my family’s life every day. Cancer, we feel, is completely behind us — and that was almost an impossible mission,” she said.
“People ask me all the time, you know, how did you cure your cancer? And I say, ‘Well, God led me to Dr. Williams.’”
“I cannot even imagine if I had stayed the course of traditional treatment and just tried to stop the progression,” said Willits. (Tina Willits)
Williams believes that immunotherapy is the future of cancer treatments.
“We first must target the tumor directly, injecting immunotherapy into it,” he said.
“In the future, the patient will be diagnosed with a suspicious lesion, and at the time of initial biopsy, we will begin treating it by injecting immunotherapy.”
Balancing risks and benefits
While immunotherapy has shown promise as an alternate treatment, it does come with its own risks and limitations for certain groups of patients.
WHY IMMUNOTHERAPY IS EMERGING AS THE ‘FOURTH PILLAR’ OF CANCER TREATMENTS, EXPERTS SAY
“Patients with autoimmune diseases have a higher risk, because the immune system is more primed to also attack normal tissues,” Williams cautioned.
“Though risks are higher, we do have techniques to overcome this, and so the benefits outweigh the risks.”
“As oncologists, we don’t want to expose a patient to a medication that can increase the risk of side effects without a clinical benefit.”
Brian Slomovitz, director of gynecologic oncology and co-chair of the Cancer Research Committee at Mount Sinai Medical Center in Florida, noted that immunotherapy has transformed the way many cancers are treated, but that it’s not always effective.
“It is important to understand that it is not useful in all patients,” said Slomovitz, who was not involved in Willits’ care.
“As oncologists, we don’t want to expose a patient to a medication that can increase the risk of side effects without a clinical benefit.”
In “properly selected” patients, however, Slomovitz believes immunotherapy can prolong both the time to cancer recurrence and overall survival rates.
Today, Willits said, she is stable and healthy. “I exercise every day,” she told Fox News Digital. (Tina Willits)
“I’m excited to watch as the field of immuno-oncology continues to evolve.”
Willits now aims to raise awareness of the availability of this treatment, as many women assume that chemotherapy, radiation and surgery are their only options.
CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER
“The reality is there are women out there who don’t know it exists,” she said. “And if we can get the word out, I can’t even tell you how many hundreds of women we could potentially save.”
She also said, “I cannot even imagine if I had stayed the course of traditional treatment and just tried to stop the progression. I mean, it’s out of my body. It’s gone. Life is back to normal again. And I am so grateful.”
“If we can get the word out, I can’t even tell you how many hundreds of women we could potentially save,” Willits said. (Tina Willits)
While Willits’ prognosis is “excellent,” Williams emphasized that “we must always be cautious and continue to monitor … Any person who has had cancer before certainly has a higher than normal risk for another cancer or a recurrence.”
For more Health articles, visit www.foxnews.com/health
For patients just starting their cancer journey, Williams says it’s critical to take the time to research the options thoroughly.
“Numerous off-label medications and supplements that are available can help enhance treatment outcomes, and exploring immunotherapy should always be a priority,” he added.
Health
Goodbye, Late-Night Cravings! How To Curb Hunger and Make Weight Loss Easier
Use left and right arrow keys to navigate between menu items.
Use escape to exit the menu.
Sign Up
Create a free account to access exclusive content, play games, solve puzzles, test your pop-culture knowledge and receive special offers.
Already have an account? Login
Health
Lurking dementia risk exposed by breakthrough test 25 years before symptoms
Study finds link between obesity and vascular dementia
Fox News senior medical analyst Dr. Marc Siegel joins ‘America’s Newsroom’ to discuss an increase in colon cancer in people under 50 despite an overall lowering cancer deaths and a new study linking obesity to vascular dementia.
NEWYou can now listen to Fox News articles!
A new blood test could determine a woman’s dementia risk as early as 25 years before symptoms emerge.
That’s according to new research from the University of California San Diego, which found that a specific biomarker protein associated with early pathological processes of Alzheimer’s disease was “strongly linked” to future dementia risk.
The researchers analyzed blood samples from 2,766 participants in the Women’s Health Initiative Memory Study in the late 1990s, according to the study’s press release.
KEY FITNESS MEASURE IS STRONG PREDICTOR OF LONGEVITY AFTER CERTAIN AGE, STUDY FINDS
The women ranged from 65 to 79 years of age and showed no signs of cognitive decline at the start of the study.
After tracking the participants for up to 25 years, the researchers concluded that the biomarker phosphorylated tau 217 (p-tau217) was “strongly associated” with future mild cognitive impairment and dementia.
A new blood test could determine a woman’s dementia risk as early as 25 years before symptoms emerge. (iStock)
Women who had higher levels of p-tau217 at the beginning of the study were “much more likely” to develop the disease. The findings were published today in JAMA Network Open.
“The key takeaway is that our study suggests it may be possible to detect risk of dementia two decades in advance using a simple blood test in older women,” first author Aladdin H. Shadyab, a UC San Diego associate professor of public health and medicine, told Fox News Digital.
“These biomarkers may help us identify who is at greatest risk and develop strategies to delay or prevent dementia.”
“Our findings show that the blood biomarker p-tau217 could help identify individuals at higher risk for dementia long before symptoms begin,” he added.
This long lead time could open the door to earlier prevention strategies and more targeted monitoring, rather than waiting until memory problems are already affecting daily life, according to Shadyab.
A specific biomarker protein associated with early pathological processes of Alzheimer’s disease was “strongly linked” to future dementia risk. (iStock)
“As the research advances, these biomarkers may help us identify who is at greatest risk and develop strategies to delay or prevent dementia,” he said.
This risk relationship wasn’t the same across the board, however. Women over 70 with higher p-tau217 levels had “poorer cognitive outcomes” compared to those under 70, as did those with the APOE ε4 gene, which is a known risk factor for Alzheimer’s disease.
The study also found that p-tau217 was a stronger predictor of dementia in women who were randomly assigned to receive estrogen and progestin hormone therapy compared to those who received a placebo.
CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER
“Blood-based biomarkers like p-tau217 are especially promising because they are far less invasive and potentially more accessible than brain imaging or spinal fluid tests,” said senior author Linda K. McEvoy, senior investigator at Kaiser Permanente Washington Health Research Institute and professor emeritus at the Herbert Wertheim School of Public Health, in the release.
“Blood-based biomarkers like p-tau217 are especially promising because they are far less invasive and potentially more accessible than brain imaging or spinal fluid tests,” a researcher said. (iStock)
“This is important for accelerating research into the factors that affect the risk of dementia and for evaluating strategies that may reduce risk.”
Blood tests for Alzheimer’s disease are still being studied and are not recommended for routine screening in people without symptoms, Shadyab noted.
TEST YOURSELF WITH OUR LATEST LIFESTYLE QUIZ
More research is needed before this approach can be considered for clinical use prior to cognitive symptoms.
Future studies should investigate how other factors — like genetics, hormone therapy and age-related medical conditions — might interact with plasma p-tau217, the researchers added.
CLICK HERE FOR MORE HEALTH STORIES
“The study examined only older women, so the findings may not necessarily apply to men or younger populations,” Shadyab noted. “We also examined overall dementia outcomes rather than specific subtypes such as Alzheimer’s disease.”
Health
Key fitness measure is strong predictor of longevity after certain age, study finds
NEWYou can now listen to Fox News articles!
For women over 60, muscle strength plays a critical role in longevity, a new study confirms.
Researchers at the University at Buffalo, New York, followed more than 5,000 women between the ages of 63 and 99, finding that those with greater muscle strength had a significantly lower risk of death over an eight-year period.
The findings were published in JAMA Network Open.
EXERCISE AFFECTS THE HEART IN A HIDDEN, POWERFUL WAY BY REWIRING NERVES, STUDY FINDS
Muscle function was measured using grip strength and how quickly participants could complete five unassisted sit-to-stand chair raises.
These are two tests commonly used in clinical settings to evaluate muscle function in older adults, the researchers noted.
A recent study shows that stronger muscle strength in women over 60 is linked to a lower risk of death over eight years. (iStock)
“In a community cohort of ambulatory older women, muscular strength was associated with significantly lower mortality rates, even when we accounted for usual physical activity and sedentary time measured using a wearable monitor, gait speed and blood C-reactive protein levels,” study lead author Michael LaMonte, research professor of epidemiology and environmental health at the University at Buffalo, told Fox News Digital.
“Movement is the key — just move more and sit less.”
Many earlier studies did not include those objective measurements, making it difficult to determine whether muscle strength itself was linked to longevity, according to LaMonte. “Our study was able to better isolate the association between strength and death in later life,” he added.
Even for women who don’t get the recommended amount of aerobic physical activity, which is at least 150 minutes per week, muscle strength remained important for longevity, the researchers found.
Women with greater muscle strength were more likely to live longer, even if they did not meet the recommended amount of aerobic exercise. (iStock)
“The findings of lower mortality in those who had higher strength but were not meeting current national guidelines on aerobic activity were somewhat intriguing,” LaMonte said.
CLICK HERE FOR MORE LIFESTYLE STORIES
Federal guidelines recommend strengthening activities one to two days per week, targeting major muscle groups.
Resistance training does not have to require a gym membership, LaMonte noted. These exercises can be performed using free weights, resistance bands, bodyweight movements or even household items, such as soup cans.
Experts recommend working major muscle groups one or two days a week using weights, bands or bodyweight exercises. (iStock)
“Movement is the key — just move more and sit less,” he said. “When we can no longer get out of the chair and move around, we are in trouble.”
TEST YOURSELF WITH OUR LATEST LIFESTYLE QUIZ
LaMonte acknowledged several limitations of the study. The researchers assessed muscle strength in older age but did not explore how earlier levels in adulthood might influence long-term health outcomes.
CLICK HERE TO DOWNLOAD THE FOX NEWS APP
“We were not able to understand how strength and mortality relate in younger ages,” he said, noting that future research should explore whether building strength earlier could have an even greater impact on longevity.
-
Wisconsin1 week agoSetting sail on iceboats across a frozen lake in Wisconsin
-
Massachusetts1 week agoMassachusetts man awaits word from family in Iran after attacks
-
Pennsylvania6 days agoPa. man found guilty of raping teen girl who he took to Mexico
-
Florida1 week agoFlorida man rescued after being stuck in shoulder-deep mud for days
-
Detroit, MI5 days agoU.S. Postal Service could run out of money within a year
-
Miami, FL6 days agoCity of Miami celebrates reopening of Flagler Street as part of beautification project
-
Sports6 days agoKeith Olbermann under fire for calling Lou Holtz a ‘scumbag’ after legendary coach’s death
-
Virginia7 days agoGiants will hold 2026 training camp in West Virginia